Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review

Defne Baskurt1, Secil Vural1,2, Sümeyre S Ertekin2

  • 1School of Medicine, Koç University, Istanbul, Turkey.

PubMed
Abstract

Insights

Xeroderma pigmentosum (XP) patients frequently develop oral lesions, including various cancers. Early oral examinations are vital for managing these potentially life-threatening conditions in children with XP.

Area of Science:

  • Genetics and Molecular Biology
  • Oncology
  • Dermatology

Background:

  • Xeroderma pigmentosum (XP) is a rare genetic disorder impairing DNA repair, leading to UV-induced damage and increased cancer risk.
  • XP patients often develop neoplasms, with oral manifestations being less characterized but significant.
  • Current XP management focuses on sun protection and malignancy surveillance, lacking specific oral care guidelines.

Approach:

  • A comprehensive literature review was performed.
  • The review focused on evaluating the prevalence and characteristics of oral mucosal lesions in pediatric XP patients.
  • Data from 130 pediatric XP patients with oral involvement were analyzed.

Key Points:

  • The study identified 210 oral lesions (tumoral and non-tumoral) in pediatric XP patients.
  • Squamous cell carcinoma was the most prevalent oral malignancy.
  • Other reported oral malignancies included basal cell carcinoma, melanoma, angiosarcoma, fibrosarcoma, and trichilemmal carcinoma.

Conclusions:

  • Oral mucosal tumors in XP patients pose significant morbidity and mortality risks.
  • Early diagnosis and prompt treatment of oral lesions are critical for improved outcomes.
  • Routine oral examinations should be integrated into the dermatological care of pediatric XP patients.